Basic helix-loop-helix family member e41 (BHLHE41)

Basic helix-loop-helix family member e41 (BHLHE41), commonly known as DEC2 or SHARP1, is a nuclear transcription factor that functions primarily as a transcriptional repressor. It plays a critical role in the molecular clock by inhibiting the transactivation of core circadian genes, and mutations in BHLHE41 are famously associated with the 'short sleep' phenotype in humans. Beyond its role in sleep and rhythmicity, BHLHE41 is a significant regulator of tumor biology, particularly in triple-negative breast cancer, where it suppresses metastasis by promoting the degradation of hypoxia-inducible factors (HIFs). It is also involved in immune cell fate, specifically in the differentiation of T helper cells and the maintenance of alveolar macrophages. While direct small-molecule inhibitors or activators are still in early research stages, BHLHE41 is considered a promising therapeutic target for managing sleep disorders and inhibiting cancer progression.

Other names

DEC2SHARP1BHLHB3Class E basic helix-loop-helix protein 41Differentially expressed in chondrocytes protein 2Enhancer-of-split and hairy-related protein 1

BHLHE41 acts as a transcriptional repressor by binding to E-box elements (CANNTG) in target gene promoters, often competing with activators like CLOCK/BMAL1. It also interacts with and promotes the proteasomal degradation of hypoxia-inducible factors (HIF-1α and HIF-2α), thereby inhibiting hypoxia-driven metastatic pathways.